London and Manchester Pharmacy Conferences
We have chosen new venues for this year's London and Manchester pharmacy conferences because we have been over-subscribed in the past.
Our conferences will take place on 15 April 2015 at Stationers' Hall, Ave Maria Lane, London EC4M 7DD, and on 16 April 2015 at the Hilton DoubleTree, One Piccadilly Place, 1 Auburn Street, Manchester M1 3DG. The programme will include:
Market entry update - insights into recent decisions Regulatory update - red flags and forthcoming changes in pharmacy law Transactions and the impact of employment law How does the GPhC Fitness to Practise Committee make decisions? Take part in a mock hearing The conferences are free, subject to availability. To request a place, contact email@example.com.
Terms of Service - Repeat Dispensing
The market entry regulations don't get updated very often, but from 1 March 2015, the NHS terms of service were amended to require pharmacy owners to support the uptake of the repeat dispensing service by informing patients on long-term, stable medical conditions of the benefits of the service. Appropriate patients must be encouraged to discuss repeat dispensing with their GP.
At the time of writing, it is far from clear whether Lord Saatchi's controversial Medical Innovation Bill will reach the Statute book. The Bill was due to have its second reading in the House of Commons on 27 February. The bill is intended to "encourage responsible innovation in medical treatment and to deter reckless departure from standard practice". If the Bill is passed, the law will be changed so that a doctor cannot be sued for negligence if he or she departs from the pre-existing range of accepted treatments for a condition, provided the doctor acts responsibly. The Bill makes no mention of pharmacists: so if a doctor goes out on a limb by prescribing something experimental or prescribes a medicine that is not licensed for the patient's condition, an injured patient would not be able to sue the doctor. But the Bill would not prevent patients from suing pharmacists who dispense prescriptions for experimental or unlicensed medicines.
A waste of taxpayers' money
Some years ago, we went to the Court of Appeal to establish on behalf of a client that if a Primary Care Trust or NHS England believes a pharmacy owner has been overpaid, the NHS body must use the procedures in NHS Regulations for recovering the sum claimed.
One CCG recently...